Biomarker tests could someday help improve outcomes for organ transplant patients

January 31, 2018, American Chemical Society

Organ transplants save lives, but the story doesn't end when a patient emerges from the operating room. Rejection episodes, in which the immune system rallies against the new organ, can occur. According to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, researchers are turning to biomarkers to help them get a better idea of which patients are more likely to have an episode.

Senior Editor Celia Henry Arnaud reports that more than 33,000 organs were transplanted in the U.S. in 2016, and as many as 15 percent of patients receiving transplants experience acute rejection. At present, the only way to monitor how well the transplant worked is to put a needle into the organ and take a biopsy weeks, months and even years afterward. But a biopsy is invasive and comes with potential complications. And then there's the time, expense and anxiety associated with the procedure. That's why researchers are investigating whether biomarkers—often, or proteins—in the blood or urine could be used as an initial noninvasive test before resorting to a biopsy.

Researchers explain that current biomarkers fall short. For example, creatinine has been used for decades to monitor , but it's not accurate enough. So, various teams are now hunting for other markers, such as RNA levels; the composition of vesicles called exosomes; and the presence of "proteoforms," which are modified proteins. To begin the process of getting these discoveries to patients, the National Institutes of Health funded a consortium to run some of these biomarkers through clinical trials. There have been positive results, but it's still unclear whether treating patients based on the markers will alter their outcomes. That's the hope, but as one researcher says, "We have our work cut out for us."

Explore further: Urinary markers may indicate prognosis after kidney transplantation

More information: Uncovering the hidden signs of organ transplant rejection, cen.acs.org/articles/96/i5/unc … plant-rejection.html

Related Stories

Urine test can diagnose, predict kidney transplant rejection

July 3, 2013

Analysis of three biomarkers in the urine of kidney transplant recipients can diagnose—and even predict—transplant rejection, according to results from a clinical trial sponsored by the National Institute of Allergy and ...

Refocusing the boom in biomarker research

July 27, 2011

An article in the current edition of Chemical & Engineering News, ACS's weekly newsmagazine, describes the trials, tribulations, and triumphs of one of the hottest pursuits in modern biomedical science — the search for ...

Recommended for you

A new way to make biaxial nematic phase liquid crystals

May 18, 2018

A team of researchers from the University of Colorado in the U.S. and Université Paris-Saclay, in France has developed a new way to make biaxial nematic phase liquid crystals. In their paper published in the journal Science, ...

Scientists make vitamin B12 breakthrough

May 17, 2018

Scientists at the University of Kent have made a significant discovery about how the vitamin content of some plants can be improved to make vegetarian and vegan diets more complete.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.